Detection of Fusion Genes Using a Targeted RNA Sequencing Panel in Gastrointestinal and Rare Cancers

Table 1

Patient characteristics.

Variables	Total
	No	%
Sex
Male	68	55.7
Female	54	44.3
Age, years
Median (range), years	58 (31–81)
Primary cancer site and histology
Colorectal cancer (ADC)	28	23.0
Biliary tract cancer (ADC)	27	22.1
Gastric cancer (ADC)	25	20.5
Soft tissue sarcoma	18	14.8
Pancreatic cancer	9	7.4
GY cancer (ADC)	9	7.4
Ovarian cancer	6	4.9
Uterine cervical cancer	1	0.8
Fallopian tube cancer	1	0.8
Skin cancer	3	2.5
Melanoma	1	0.8
Skin squamous cell carcinoma	1	0.8
Trichilemmal carcinoma	1	0.8
Adenoid cystic carcinoma	1	0.8
Hepatocellular carcinoma	1	0.8
Pseudomyxoma peritonei	1	0.8
Urachal cancer	1	0.8
Initial stage
Locoregional disease	67	54.9
Metastatic	55	45.1
Number of prior systemic treatment regimens
1	32	26.2
2	31	25.4
3	24	19.7
≥4	26	21.3
Site of distant metastasis
Liver	38	31.4
Peritoneal seeding	33	27.3
Lung	27	22.3
Lymph node	27	22.3
Bone	13	10.7
Ovary	9	7.4
Pleura	7	5.8